Lv3
270 积分 2022-08-28 加入
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
3小时前
待确认
Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study
2个月前
已完结
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
4个月前
已完结
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
4个月前
已完结
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial
4个月前
已完结
SBRT feasible for oligometastatic RCC
4个月前
已完结
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
4个月前
已完结
LDHA‐mediated M2‐type macrophage polarization via tumor‐derived exosomal EPHA2 promotes renal cell carcinoma progression
11个月前
已完结
肾动脉分支阻断与主干阻断在机器人辅助腹腔镜肾部分切除术治疗早期肾癌中的疗效对比
1年前
已完结
肾动脉分支阻断与主干阻断在机器人辅助腹腔镜肾部分切除术治疗早期肾癌中的疗效对比
1年前
已关闭
皖公网安备34019202002308
